Aura Biosciences (AURA) Prepaid Assets (2020 - 2026)
Aura Biosciences (AURA) reported Prepaid Assets of $1.2 million for Q1 2026, down 1.19% on a YoY basis from $1.2 million in Q1 2025, and down 30.49% quarter-over-quarter from $1.7 million in Q4 2025.
Aura Biosciences (AURA) Prepaid Assets (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Prepaid Assets for 7 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 1.19% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 1.19% YoY), and the FY2025 full-year result was $1.7 million, down 1.77% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.2 million, down from $1.7 million in the prior quarter.
- The five-year high for Prepaid Assets was $5.6 million in Q4 2023, with the low at $131000.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $1.7 million across 5 years, with a median of $1.2 million in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 983.33% — and 2025, when it slumped 73.78%.
- Aura Biosciences' Prepaid Assets stood at $715000.0 in 2022, then soared by 686.71% to $5.6 million in 2023, then sank by 69.85% to $1.7 million in 2024, then decreased by 1.77% to $1.7 million in 2025, then tumbled by 30.49% to $1.2 million in 2026.
- The last three Prepaid Assets figures came in at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 648,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 5.63 Mn |
| Sep 30, 2023 | 566,000.00 |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 771,000.00 |
| Dec 31, 2022 | 715,000.00 |
| Sep 30, 2022 | 417,000.00 |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 80,000.00 |
| Dec 31, 2020 | 16,000.00 |